NYSE:ALB - Albemarle Stock Price, News, & Analysis

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle declared a quarterly dividend on Tuesday, October 30th. Shareholders of record on Friday, December 14th will be paid a dividend of $0.335 per share on Wednesday, January 2nd. This represents a $1.34 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date is Thursday, December 13th. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) announced its quarterly earnings results on Wednesday, November, 7th. The specialty chemicals company reported $1.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.25 by $0.06. The specialty chemicals company had revenue of $778 million for the quarter, compared to analysts' expectations of $796.79 million. Albemarle had a return on equity of 15.39% and a net margin of 10.44%. The firm's revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.08 EPS. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Tuesday, February 26th 2019. View Earnings Estimates for Albemarle.

Albemarle updated its FY18 earnings guidance on Wednesday, November, 7th. The company provided EPS guidance of $5.30-5.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.39. The company issued revenue guidance of $3.3-3.5 billion, compared to the consensus revenue estimate of $3.37 billion.Albemarle also updated its FY 2018 guidance to $5.30-5.50 EPS.

20 analysts have issued 12 month target prices for Albemarle's shares. Their predictions range from $85.00 to $150.00. On average, they expect Albemarle's stock price to reach $123.6058 in the next year. This suggests a possible upside of 29.1% from the stock's current price. View Analyst Price Targets for Albemarle.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 1 hold rating and 17 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Albemarle.

News stories about ALB stock have trended somewhat positive on Wednesday, according to InfoTrie. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Albemarle earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave news headlines about the specialty chemicals company a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an impact on the company's share price in the immediate future.

Some companies that are related to Albemarle include Eastman Chemical (EMN), Hexcel (HXL), Sinopec Shanghai Petrochemical (SHI), PolyOne (POL), Rogers (ROG), Trinseo (TSE), AdvanSix (ASIX), Kraton (KRA), A Schulman (SHLM), Cereplast (CERPQ) and ForceField Energy (FNRG).

Albemarle's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Franklin Resources Inc. (8.51%), Jennison Associates LLC (7.28%), BlackRock Inc. (6.84%), Bank of New York Mellon Corp (3.95%), Baillie Gifford & Co. (2.47%) and Iridian Asset Management LLC CT (1.79%). Company insiders that own Albemarle stock include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, BlackRock Inc., Janus Henderson Group PLC, Franklin Resources Inc., Mitsubishi UFJ Trust & Banking Corp, JPMorgan Chase & Co., JPMorgan Chase & Co. and Barings LLC. View Insider Buying and Selling for Albemarle.

ALB stock was purchased by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Mirae Asset Global Investments Co. Ltd., Primecap Management Co. CA, Jennison Associates LLC, Earnest Partners LLC, Allianz Asset Management GmbH, SG Americas Securities LLC and Robecosam AG. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $95.74.

Albemarle has a market capitalization of $10.58 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $4.59 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.

The official website for Albemarle is http://www.albemarle.com.

Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700.